Related Experiment Video
Updated: Aug 11, 2025

07:15
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020
6.9K
Applications of Deep Learning in Endocrine Neoplasms
Siddhi Ramesh1, James M Dolezal1, Alexander T Pearson2
1Department of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center, 5841 South Maryland Avenue, MC 2115, Chicago, IL 60637, USA; The University of Chicago Medicine & Biological Sciences, 5841 South Maryland Avenue, Chicago, IL, USA.
Surgical Pathology Clinics
|February 4, 2023
Summary
Deep learning (DL) advances computational analysis of endocrine cancer histopathology for diagnosis and characterization. This review covers DL
Area of Science:
- Medical Informatics
- Computational Pathology
- Oncology
Background:
- Machine learning (ML) and deep learning (DL) are increasingly vital in medical applications.
- DL enables computational analysis of histological samples, supporting diagnosis and characterization in various diseases.
- DL shows promise in endocrine cancer research for tasks like tumor grading and gene expression prediction.
Purpose of the Study:
- To review the current applications of deep learning (DL) in endocrine cancer histopathology.
- To emphasize experimental design, key findings, and limitations in existing DL research for endocrine cancers.
Main Methods:
- Systematic review of recent literature on deep learning in endocrine cancer histopathology.
- Analysis of studies focusing on experimental design, methodologies, and reported outcomes.
- Identification of common themes, successes, and challenges in the field.
Main Results:
- DL methods have been successfully applied to various endocrine cancer histopathology tasks.
- Significant findings include improved diagnostic accuracy and predictive capabilities.
- Identified limitations relate to data variability, model interpretability, and generalizability.
Conclusions:
- Deep learning holds significant potential to advance endocrine cancer diagnosis and research.
- Further research is needed to address current limitations and facilitate clinical translation.
- Standardization of experimental design and validation is crucial for robust DL applications in endocrine cancer histopathology.

